39,40 GSH and NAC effectively block the cytokine-induced production of virus and may extend the latency period of early infection
doi: 10.1128/CMR.00014-10 9 AmatngalimGDHiemstraPS
[Abstract]2024 Dec 27;22(1):1151
Disclosures: Taranika Sarkar Das: Nothing to Disclose, Jahnavi Udaikumar: Nothing to Disclose, Kimberly Ho: Nothing to Disclose, Carolyn Wilson: Nothing to Disclose, Inna De Leon: Nothing to Disclose, Kripali Gautam: Nothing to Disclose, Xucong Meng: Nothing to Disclose, Jennifer Stromberg: Nothing to Disclose, Raiya Sarwar: Nothing to Disclose, Saikiran Kilaru: Nothing to Disclose, Bilal Hameed: Gilead: Grant/Research Support, Intercept: Grant/Research Support, Pliant: Grant/Research Support, Novo Nordisk: Grant/Research Support, Madrigal: Grant/Research Support, Salix: Grant/Research Support, Mallinckrodt: Advisor, Pleiogenix: Advisor, CLDF: Advisor, Gilead: Consultant, Pioneering Medicine VII Inc: Consultant, Surrozen: Consultant, Pleiogenix: Stock privately held company, Scholars In Medicine: Speaking and Teaching, Aasma Shaukat: Nothing to Disclose 947 PSYCHOLOGICAL BURDENS, SYSTEM DISTRUST, AND FINANCIAL CONSTRAINTS AMONG THE BARRIERS FACING MARGINALIZED GROUPS REFERRED FOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: A QUALITATIVE STUDY Lauren Nephew 1 Courtney Moore 2 Nicole Garcia 1 Lisa Parks 2 Allison McKay 2 Alexandra Strauss 3 Sarah Wiehe 2 John Holden 1 Monica Kasting 4 Katie Ross-Driscoll 1 Marwan Ghabril 1 Eric Orman 1 Archita Desai 1 Naga Chalasani 5 Susan Rawl 1 , 1 Indiana University, 2 Indiana University Clinical and Translational Science Institute, 3 Johns Hopkins University, 4 Purdue University, 5 Indiana University Medical Center Background: Black patients and those experiencing adverse social determinants of health (SDOH) face significant disparities in accessing curative therapies for hepatocellular carcinoma (HCC), impacting their survival
